AMGN: Amgen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 146,750.67
Enterprise Value ($M) 200,419.67
Book Value ($M) 6,232.00
Book Value / Share 11.63
Price / Book 23.55
NCAV ($M) -60,590.00
NCAV / Share -113.06
Price / NCAV -2.42

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.10
Return on Equity (ROE) 1.83

Liquidity (mrq)
Quick Ratio 1.13
Current Ratio 1.65

Balance Sheet (mrq) ($M)
Current Assets 30,332.00
Assets 97,154.00
Liabilities 90,922.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 28,190.00
Operating Income 13,399.00
Net Income 6,717.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 8,471.00
Cash from Investing -26,204.00
Cash from Financing 21,048.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.16 2.02
01-30 13G/A State Street Corp 5.52 -0.73
01-25 13G/A BlackRock Inc. 8.90 -1.45

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-04-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-01 517,912 3,205,332 16.16
2024-02-29 364,996 2,868,481 12.72
2024-02-28 379,480 3,026,971 12.54
2024-02-27 600,129 3,353,933 17.89
2024-02-26 286,837 2,448,935 11.71

(click for more detail)

Similar Companies
ALVR – AlloVir, Inc. ALXO – ALX Oncology Holdings Inc.
AMAM – Ambrx Biopharma Inc. AMLX – Amylyx Pharmaceuticals, Inc.
AMPH – Amphastar Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Amgen Inc.